Results 241 to 250 of about 710,902 (311)
ABSTRACT Background Myasthenia gravis (MG) is an autoimmune disorder characterized by antibody‐mediated complement activation. Efgartigimod, a neonatal Fc receptor (FcRn) antagonist, is approved for treating generalized MG (gMG). However, its modulatory effects on upstream innate and adaptive immune cells remain largely unexplored.
Lei Jin +11 more
wiley +1 more source
Nano-Elicitation Approaches for Boosting Secondary Metabolites in Medicinal Plant Cell Cultures. [PDF]
Golkar P +2 more
europepmc +1 more source
Review of culture media and serum substitutes containing phytoecdysteroids for application in cultured meat technology. [PDF]
Park J +11 more
europepmc +1 more source
An in vitro slow-growth callus conservation strategy for several medicinal plants using response surface methodology and machine learning. [PDF]
Kim YW +4 more
europepmc +1 more source
Applying recombinant antibodies for quality control of mixed-culture peanut bradyrhizobial inoculant. [PDF]
Singtothong C +13 more
europepmc +1 more source
Cultivated Meat and the Future of Food Systems: Promise, Progress, and Challenges. [PDF]
Kim S +4 more
europepmc +1 more source

